Hypoxic-Ischemic Encephalopathy clinical trials at UC Davis
1 research study open to eligible people
A Study of Experimental Medicine Topiramate in Newborns Receiving Whole Body Cooling for Encephalopathy (type of brain damage)
open to all eligible people
The goal is to see whether topiramate (an anti-epileptic agent) improves the outcome of babies with neonatal hypoxic encephalopathy who are receiving whole body cooling.
Our lead scientists for Hypoxic-Ischemic Encephalopathy research studies include Kristin R Hoffman, MD.